MedPath

CONSTANT THERAPEUTICS LLC

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.constanttherapeutics.com

Phase 2 Study of TXA127 in Post-ischemic Stroke Patients

Phase 2
Recruiting
Conditions
Ischemic Stroke
Interventions
Drug: Placebo
First Posted Date
2023-11-18
Last Posted Date
2023-12-21
Lead Sponsor
Constant Therapeutics LLC
Target Recruit Count
50
Registration Number
NCT06135103
Locations
🇮🇱

Sheba Medical Center, Ramat Gan, Israel

TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy

Phase 2
Recruiting
Conditions
DMD-Associated Dilated Cardiomyopathy
Interventions
First Posted Date
2023-08-28
Last Posted Date
2024-01-23
Lead Sponsor
Constant Therapeutics LLC
Target Recruit Count
10
Registration Number
NCT06013839
Locations
🇮🇱

Sheba Medical Center, Ramat Gan, Israel

🇮🇱

Hadassah Medical Center, Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath